Yu et al., 2016 - Google Patents
BTG4 is a meiotic cell cycle–coupled maternal-zygotic-transition licensing factor in oocytesYu et al., 2016
View PDF- Document ID
- 2632064071207922422
- Author
- Yu C
- Ji S
- Sha Q
- Dang Y
- Zhou J
- Zhang Y
- Liu Y
- Wang Z
- Hu B
- Sun Q
- Sun S
- Tang F
- Fan H
- Publication year
- Publication venue
- Nature structural & molecular biology
External Links
Snippet
The mRNAs stored in oocytes undergo general decay during the maternal-zygotic transition (MZT), and their stability is tightly interconnected with meiotic cell-cycle progression. However, the factors that trigger decay of maternal mRNA and couple this event to oocyte …
- 101700086895 BTG4 0 title abstract description 235
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yu et al. | BTG4 is a meiotic cell cycle–coupled maternal-zygotic-transition licensing factor in oocytes | |
Rong et al. | ZAR1 and ZAR2 are required for oocyte meiotic maturation by regulating the maternal transcriptome and mRNA translational activation | |
Chen et al. | Loss of DUX causes minor defects in zygotic genome activation and is compatible with mouse development | |
Rom et al. | Regulation of CHD2 expression by the Chaserr long noncoding RNA gene is essential for viability | |
Soper et al. | Mouse maelstrom, a component of nuage, is essential for spermatogenesis and transposon repression in meiosis | |
Lu et al. | CRISPR/Cas9-mediated genome editing reveals 30 testis-enriched genes dispensable for male fertility in mice | |
Lipkin et al. | Meiotic arrest and aneuploidy in MLH3-deficient mice | |
Morgan et al. | mRNA 3′ uridylation and poly (A) tail length sculpt the mammalian maternal transcriptome | |
Yu et al. | Oocyte-expressed yes-associated protein is a key activator of the early zygotic genome in mouse | |
Abby et al. | Implementation of meiosis prophase I programme requires a conserved retinoid-independent stabilizer of meiotic transcripts | |
Ruan et al. | Highly efficient CRISPR/Cas9-mediated transgene knockin at the H11 locus in pigs | |
Luo et al. | MEIOB exhibits single-stranded DNA-binding and exonuclease activities and is essential for meiotic recombination | |
Sato et al. | The combinational use of CRISPR/Cas9‐based gene editing and targeted toxin technology enables efficient biallelic knockout of the α‐1, 3‐galactosyltransferase gene in porcine embryonic fibroblasts | |
Bai et al. | Sox30 initiates transcription of haploid genes during late meiosis and spermiogenesis in mouse testes | |
Anuar et al. | Gene editing of the multi-copy H2A. B gene and its importance for fertility | |
Takabayashi et al. | i-GONAD (improved genome-editing via oviductal nucleic acids delivery), a convenient in vivo tool to produce genome-edited rats | |
Finsterbusch et al. | Alignment of homologous chromosomes and effective repair of programmed DNA double-strand breaks during mouse meiosis require the minichromosome maintenance domain containing 2 (MCMDC2) protein | |
Miao et al. | Mediator complex component MED13 regulates zygotic genome activation and is required for postimplantation development in the mouse | |
JP6868615B2 (en) | Selection of pluripotent cells to generate reproductive XY female mice | |
Ganesh et al. | The most abundant maternal lncRNA Sirena1 acts post-transcriptionally and impacts mitochondrial distribution | |
Lankenau et al. | Knockout targeting of the Drosophila nap1 gene and examination of DNA repair tracts in the recombination products | |
Feehan et al. | Modeling dominant and recessive forms of retinitis pigmentosa by editing three rhodopsin-encoding genes in Xenopus laevis using Crispr/Cas9 | |
Ghule et al. | Fidelity of histone gene regulation is obligatory for genome replication and stability | |
Zhang et al. | PATL2 regulates mRNA homeostasis in oocytes by interacting with EIF4E and CPEB1 | |
Wu et al. | Dynamic mRNA degradome analyses indicate a role of histone H3K4 trimethylation in association with meiosis-coupled mRNA decay in oocyte aging |